An experimental gene therapy ear injection has cured deafness for 10 out of 10 patients in clinical trial.
Scientists have announced a major breakthrough in treating genetic deafness after a single ear injection successfully restored hearing in patients born deaf.
In a clinical trial, researchers delivered a healthy version of a critical hearing gene directly into the inner ear which led to measurable hearing improvements within weeks.
How it Works
The treatment targets a rare inherited form of deafness caused by mutations in the OTOF gene, which is essential for transmitting sound signals from the inner ear to the brain. Ten participants (young children and young adults) received the injection and showed big improvements in rheir hearing ability.
Most patients began responding to sounds within a month, and many reached levels where speech was clearly understood.
It was noted that average hearing thresholds improved dramatically after treatment. Younger patients showed especially notable progress, while adults and older children also experienced meaningful hearing recovery.
Unlike hearing aids and cochlear implants, which amplify sound or bypass damaged components, this gene therapy addresses the underlying genetic cause. Experts say this could pave the way toward treating a broader range of hereditary hearing loss conditions in the future.
This development represents one of the most promising advances yet in hearing restoration and could speed up cures for genetic forms of deafness.
